A number of firms have modified their ratings and price targets on shares of Novavax (NASDAQ: NVAX) recently: 1/11/2018 – Novavax was given a new $10.00 price target on by analysts at B. Riley. They now have a “buy” rating on the stock. 1/11/2018 – Novavax had its price target raised by analysts at Ladenburg […]
